Effectiveness and safety of nivolumab in patients with advanced melanoma: A multicenter, observational studyS. Monestier, Caroline Dutriaux, S. Dalac‐Rat et al.|International Journal of Cancer|2021Cited by 9
Abstract A35: A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcomaNeerav Shukla, Marc Ladanyi, Shinji Kohsaka et al.|Cancer Research|2014Cited by 1